Microtubule stabilising agents and ionising radiation: Multiple exploitable mechanisms for combined treatment

European Journal of Cancer

Volumn 49, Issue 1, 2013, Pages 245-253

  Rohrer Bley, Carla ^a,b   Furmanova, Polina ^a   Orlowski, Katrin ^a   Grosse, Nicole ^a   Broggini Tenzer, Angela ^a   McSheehy, Paul M J ^c   Pruschy, Martin ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Epothilones; Ionising radiation; Microtubule stabilising agents; Radiochemotherapy; Taxanes

Indexed keywords

CYTOTOXIC AGENT; DOCETAXEL; EPOTHILONE B; GELATINASE A; GELATINASE B; MICROTUBULE STABILIZING AGENT; PACLITAXEL; STABILIZING AGENT; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL INVASION; CELL KILLING; CHROMOSOME ABERRATION; DOUBLE STRANDED DNA BREAK; ENDOTHELIUM CELL; GENOMIC INSTABILITY; HELA CELL; HUMAN; HYPOXIA; IN VIVO STUDY; IONIZING RADIATION; IRRADIATION; MELANOMA; MITOSIS; MITOSIS INHIBITION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SECRETION; RADIATION RESPONSE; RADIOSENSITIVITY; REOXYGENATION; TUMOR XENOGRAFT;

ANIMALS; CHEMORADIOTHERAPY; HUMANS; MICROTUBULES; NEOPLASMS; RADIATION-SENSITIZING AGENTS;

EID: 84871457687     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.05.008     Document Type: Article

References (95)

1. D.M. Bollag, P.A. McQueney, and J. Zhu Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action Cancer Res 55 11 1995 2325 2333
2. R.J. Kowalski, P. Giannakakou, and E. Hamel Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)) J Biol Chem 272 4 1997 2534 2541 (Pubitemid 27058547)
3. J.J. Manfredi, J. Parness, and S.B. Horwitz Taxol binds to cellular microtubules J Cell Biol 94 3 1982 688 696 (Pubitemid 13241201)
4. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci U S A 77 3 1980 1561 1565 (Pubitemid 10073801)
5. A. Canales, J. Rodriguez-Salarichs, and C. Trigili Insights into the interaction of discodermolide and docetaxel with tubulin. Mapping the binding sites of microtubule-stabilizing agents by using an integrated NMR and computational approach ACS Chem Biol 6 8 2011 789 799
6. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat Rev Cancer 4 4 2004 253 265 (Pubitemid 38525281)
7. J.A. Sparano Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials Clin Breast Cancer 1 1 2000 32 40 [discussion 41-2]
8. P. Bonomi, K. Kim, and D. Fairclough Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial J Clin Oncol 18 3 2000 623 631 (Pubitemid 30078543)
9. J.J. Lee, and L.N. Harris Antimicrotubule agents V.T. De Vita, T.S. Lawrence, S.A. Rosenberg, Cancer, principles & practice of oncology 8th ed. 2008 Lippincott Williams & Wilkins Philadelphia 447 456
10. G. Klautke, T. Foitzik, and K. Ludwig Neoadjuvant radiochemotherapy in locally advanced gastric carcinoma Strahlenther Onkol 180 11 2004 695 700 (Pubitemid 40022276)
11. B.J. Leibl, S. Vitz, and W. Schafer Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery: early results and toxicity Strahlenther Onkol 187 4 2011 231 237
12. L. Liu, N. Vapiwala, and L.K. Munoz A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors Med Pediatr Oncol 37 4 2001 390 392 (Pubitemid 32959651)
13. D.I. Rosenthal, C.D. Fuller, and M. Machtay Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer J Thorac Oncol 1 1 2006 38 45 (Pubitemid 47164019)
14. D.I. Rosenthal, J.H. Lee, and R. Sinard Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck J Clin Oncol 19 5 2001 1363 1373 (Pubitemid 32202542)
15. S. Fogh, M. Machtay, and M. Werner-Wasik Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies Int J Radiat Oncol Biol Phys 77 4 2010 1009 1016
16. D.I. Rosenthal, L.G. Close, and J.A. Lucci 3rd Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors Semin Oncol 22 4 Suppl. 9 1995 13 17
17. P.H. Wiernik, E.L. Schwartz, and A. Einzig Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma J Clin Oncol 5 8 1987 1232 1239 (Pubitemid 18045309)
18. P.H. Wiernik, E.L. Schwartz, and J.J. Strauman Phase I clinical and pharmacokinetic study of taxol Cancer Res 47 9 1987 2486 2493 (Pubitemid 17099218)
19. S.E. Jones, J. Erban, and B. Overmoyer Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer J Clin Oncol 23 24 2005 5542 5551
20. I.F. Tannock, R. de Wit, and W.R. Berry Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 15 2004 1502 1512 (Pubitemid 39315317)
21. E. Van Cutsem, V.M. Moiseyenko, and S. Tjulandin Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group J Clin Oncol 24 31 2006 4991 4997 (Pubitemid 46631401)
22. M.J. Edelman Novel taxane formulations and microtubule-binding agents in non-small-cell lung cancer Clin Lung Cancer 10 Suppl. 1 2009 S30 S34
23. J.H. Nettles, H. Li, B. Cornett, J.M. Krahn, J.P. Snyder, and K.H. Downing The binding mode of epothilone A on alpha, beta-tubulin by electron crystallography Science 305 5685 2004 866 869 (Pubitemid 39038421)
24. K.H. Altmann, and J. Gertsch Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents Nat Prod Rep 24 2 2007 327 357 (Pubitemid 46504987)
25. K.H. Altmann, B. Pfeiffer, S. Arseniyadis, B.A. Pratt, and K.C. Nicolaou The chemistry and biology of Epothilones-the wheel keeps turning ChemMedChem 2 4 2007 396 423
26. K.H. Altmann, M. Wartmann, and T. O'Reilly Epothilones and related structures-a new class of microtubule inhibitors with potent in vivo antitumor activity Biochim Biophys Acta 1470 3 2000 M79 M91
27. W. Gradishar Management of advanced breast cancer with the epothilone B analog, ixabepilone Drug Des Devel Ther 3 2009 163 171
28. Dumontet C, Jordan MA. Microtubule-binding agents: a dynamic field of cancer therapeutics. Nat Rev Drug Discov 9(10):790-803.
29. R.A. Freedman, E. Bullitt, and L. Sun A Phase II study of Sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases Clin Breast Cancer 11 6 2011 376 383
30. G. Rustin, N. Reed, and G.C. Jayson A phase II trial evaluating two schedules of sagopilone (ZK-EPO), a novel epothilone, in patients with platinum-resistant ovarian cancer Ann Oncol 22 11 2011 2411 2416
31. R. Stupp, A. Tosoni, and J.E. Bromberg Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group. Ann Oncol 22 9 2011 2144 2149
32. G.G. Steel Terminology in the description of drug-radiation interactions Int J Radiat Oncol Biol Phys 5 8 1979 1145 1150 (Pubitemid 10215318)
33. G.G. Steel, and M.J. Peckham Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity Int J Radiat Oncol Biol Phys 5 1 1979 85 91 (Pubitemid 9120186)
34. S.M. Bentzen, P.M. Harari, and J. Bernier Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions Nat Clin Pract Oncol 4 3 2007 172 180 (Pubitemid 46358854)
35. L. Milas, M.M. Milas, and K.A. Mason Combination of taxanes with radiation: preclinical studies Semin Radiat Oncol 9 2 Suppl. 1 1999 12 26 (Pubitemid 29190407)
36. C.G. Milross, K.A. Mason, and N.R. Hunter Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel J Natl Cancer Inst 88 18 1996 1308 1314 (Pubitemid 26301619)
37. C.G. Milross, K.A. Mason, and N.R. Hunter Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo Eur J Cancer 33 8 1997 1299 1308 (Pubitemid 27359652)
38. W.K. Sinclair, and R.A. Morton X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells Radiat Res 29 3 1966 450 474
39. T. Terasima, and L.J. Tolmach Variations in several responses of HeLa cells to x-irradiation during the division cycle Biophys J 3 1963 11 33
40. T.M. Pawlik, and K. Keyomarsi Role of cell cycle in mediating sensitivity to radiotherapy Int J Radiat Oncol Biol Phys 59 4 2004 928 942 (Pubitemid 38834285)
41. C.R. Geard, J.M. Jones, and P.B. Schiff Taxol and radiation J Natl Cancer Inst Monogr 15 1993 89 94
42. J.S. Kim, G.P. Amorino, and H. Pyo The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells Int J Radiat Oncol Biol Phys 51 2 2001 525 534 (Pubitemid 32884300)
43. J. Liebmann, J.A. Cook, J. Fisher, D. Teague, and J.B. Mitchell In vitro studies of Taxol as a radiation sensitizer in human tumor cells J Natl Cancer Inst 86 6 1994 441 446 (Pubitemid 24081876)
44. M. Lobrich, and P.A. Jeggo The impact of a negligent G2/M checkpoint on genomic instability and cancer induction Nat Rev Cancer 7 11 2007 861 869 (Pubitemid 350006255)
45. A. Steren, B.U. Sevin, and J. Perras Taxol sensitizes human ovarian cancer cells to radiation Gynecol Oncol 48 2 1993 252 258 (Pubitemid 23075182)
46. T. Baumgart, G. Klautke, and S. Kriesen Radiosensitizing effect of epothilone B on human epithelial cancer cells Strahlenther Onkol 188 2 2012 177 184
47. N. Gupta, L.J. Hu, and D.F. Deen Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation Int J Radiat Oncol Biol Phys 37 4 1997 885 895 (Pubitemid 27181323)
48. C.E. Leonard, D.C. Chan, T.C. Chou, R. Kumar, and P.A. Bunn Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck Cancer Res 56 22 1996 5198 5204 (Pubitemid 26383036)
49. J. Liebmann, J.A. Cook, J. Fisher, D. Teague, and J.B. Mitchell Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol) Int J Radiat Oncol Biol Phys 29 3 1994 559 564 (Pubitemid 24187928)
50. R.B. Tishler, C.R. Geard, E.J. Hall, and P.B. Schiff Taxol sensitizes human astrocytoma cells to radiation Cancer Res 52 12 1992 3495 3497
51. G.D. Zanelli, M. Quaia, and I. Robieux Paclitaxel as a radiosensitiser: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations Eur J Cancer 33 3 1997 486 492 (Pubitemid 27168078)
52. K.A. Mason, N.R. Hunter, M. Milas, J.L. Abbruzzese, and L. Milas Docetaxel enhances tumor radioresponse in vivo Clin Cancer Res 3 12 Pt 1 1997 2431 2438 (Pubitemid 28133165)
53. K.A. Mason, L. Milas, and L.J. Peters Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa Int J Radiat Oncol Biol Phys 32 5 1995 1381 1389
54. L. Milas, Y. Saito, N. Hunter, C.G. Milross, and K.A. Mason Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma Radiother Oncol 40 2 1996 163 170 (Pubitemid 26276682)
55. B. Hofstetter, V. Vuong, and A. Broggini-Tenzer Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo Clin Cancer Res 11 4 2005 1588 1596 (Pubitemid 40315244)
56. C. Hennequin, N. Giocanti, and V. Favaudon S-phase specificity of cell killing by docetaxel (Taxotere) in synchronised HeLa cells Br J Cancer 71 6 1995 1194 1198
57. C. Hennequin, N. Giocanti, and V. Favaudon Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells Cancer Res 56 8 1996 1842 1850
58. L. Milas, N.R. Hunter, K.A. Mason, B. Kurdoglu, and L.J. Peters Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel Cancer Res 54 13 1994 3506 3510 (Pubitemid 24225974)
59. L. Milas, N.R. Hunter, and K.A. Mason Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel Cancer Res 55 16 1995 3564 3568
60. M. Garcia-Barros, F. Paris, and C. Cordon-Cardo Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 300 5622 2003 1155 1159 (Pubitemid 36583102)
61. S. Honore, E. Pasquier, and D. Braguer Understanding microtubule dynamics for improved cancer therapy Cell Mol Life Sci 62 24 2005 3039 3056 (Pubitemid 43004753)
62. C.R. Bley, W. Jochum, and K. Orlowski Role of the microenvironment for radiosensitization by patupilone Clin Cancer Res 15 4 2009 1335 1342
63. D. Escuin, E.R. Kline, and P. Giannakakou Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function Cancer Res 65 19 2005 9021 9028 (Pubitemid 41377394)
64. G. Bocci, K.C. Nicolaou, and R.S. Kerbel Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs Cancer Res 62 23 2002 6938 6943 (Pubitemid 35424084)
65. Stalder MW, Anthony CT, Woltering EA. Metronomic dosing enhances the anti-angiogenic effect of epothilone B. J Surg Res 169(2):247-256.
66. E. Pasquier, M. Carre, and B. Pourroy Antiangiogenic activity of paclitaxel is associated with its cytostatic effect, mediated by the initiation but not completion of a mitochondrial apoptotic signaling pathway Mol Cancer Ther 3 10 2004 1301 1310 (Pubitemid 39440174)
67. S. Ferretti, P.R. Allegrini, and T. O'Reilly Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure Clin Cancer Res 11 21 2005 7773 7784 (Pubitemid 41611621)
68. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 5706 2005 58 62 (Pubitemid 40093472)
69. Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10(6):417-427.
70. D.H. Lau, L. Xue, L.J. Young, P.A. Burke, and A.T. Cheung Paclitaxel (Taxol): an inhibitor of angiogenesis in a highly vascularized transgenic breast cancer Cancer Biother Radiopharm 14 1 1999 31 36 (Pubitemid 29157732)
71. C. Rohrer Bley, K. Orlowski, P. Furmanova, P.M. McSheehy, and M. Pruschy Regulation of VEGF-expression by patupilone and ionizing radiation in lung adenocarcinoma cells Lung Cancer 73 3 2011 294 301
72. R.C. Borghaei, G. Gorski, and M. Javadi NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter Biochem Biophys Res Commun 382 2 2009 269 273
73. L. Agemy, A. Harmelin, and T. Waks Irradiation enhances the metastatic potential of prostatic small cell carcinoma xenografts Prostate 68 5 2008 530 539 (Pubitemid 351500213)
74. K. Camphausen, M.A. Moses, and W.D. Beecken Radiation therapy to a primary tumor accelerates metastatic growth in mice Cancer Res 61 5 2001 2207 2211 (Pubitemid 32692049)
75. U. Jadhav, and S. Mohanam Response of neuroblastoma cells to ionizing radiation: modulation of in vitro invasiveness and angiogenesis of human microvascular endothelial cells Int J Oncol 29 6 2006 1525 1531
76. L.W. Qian, K. Mizumoto, and T. Urashima Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023 Clin Cancer Res 8 4 2002 1223 1227 (Pubitemid 35177378)
77. W.J. Speake, R.A. Dean, and A. Kumar Radiation induced MMP expression from rectal cancer is short lived but contributes to in vitro invasion Eur J Surg Oncol 31 8 2005 869 874 (Pubitemid 41435256)
78. J.C. Cheng, C.H. Chou, M.L. Kuo, and C.Y. Hsieh Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway Oncogene 25 53 2006 7009 7018 (Pubitemid 44722069)
79. C.M. Park, M.J. Park, and H.J. Kwak Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways Cancer Res 66 17 2006 8511 8519
80. C. Strup-Perrot, M.C. Vozenin-Brotons, M. Vandamme, C. Linard, and D. Mathe Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells World J Gastroenterol 11 40 2005 6312 6321 (Pubitemid 43013999)
81. H. Susskind, M.H. Hymowitz, and Y.H. Lau Increased plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung and breast cancer are altered during chest radiotherapy Int J Radiat Oncol Biol Phys 56 4 2003 1161 1169 (Pubitemid 36794051)
82. A.G. Remacle, D.V. Rozanov, and P.C. Baciu The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP) J Cell Sci 118 Pt 21 2005 4975 4984 (Pubitemid 41672429)
83. O. Sbai, L. Ferhat, and A. Bernard Vesicular trafficking and secretion of matrix metalloproteinases-2, -9 and tissue inhibitor of metalloproteinases-1 in neuronal cells Mol Cell Neurosci 39 4 2008 549 568
84. E.M. Schnaeker, R. Ossig, and T. Ludwig Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion Cancer Res 64 2004 8924 8931 (Pubitemid 39665499)
85. M.E. Stearns, and M. Wang Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases Cancer Res 52 13 1992 3776 3781
86. M.N. Bijman, G.P. van Nieuw Amerongen, N. Laurens, V.W. van Hinsbergh, and E. Boven Microtubule-targeting agents inhibit angiogenesis at subtoxic concentrations, a process associated with inhibition of Rac1 and Cdc42 activity and changes in the endothelial cytoskeleton Mol Cancer Ther 5 9 2006 2348 2357 (Pubitemid 44530472)
87. Y.L. Hu, S. Li, and H. Miao Roles of microtubule dynamics and small GTPase Rac in endothelial cell migration and lamellipodium formation under flow J Vasc Res 39 6 2002 465 476 (Pubitemid 36091837)
88. J. Wiskirchen, W. Schober, and N. Schart The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study Invest Radiol 39 9 2004 565 571 (Pubitemid 39096774)
89. M. Ogasawara, T. Matsubara, and H. Suzuki Screening of natural compounds for inhibitory activity on colon cancer cell migration Biol Pharm Bull 24 6 2001 720 723 (Pubitemid 32586670)
90. A. Westerlund, E. Hujanen, M. Hoyhtya, U. Puistola, and T. Turpeenniemi-Hujanen Ovarian cancer cell invasion is inhibited by paclitaxel Clin Exp Metastasis 15 3 1997 318 328 (Pubitemid 27240360)
91. H. Jiang, W. Tao, and M. Zhang Low-dose metronomic paclitaxel chemotherapy suppresses breast tumors and metastases in mice Cancer Invest 28 1 2010 74 84
92. T. O'Reilly, M. Wartmann, and J. Brueggen Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo Cancer Chemother Pharmacol 62 6 2008 1045 1054
93. A. Strube, J. Hoffmann, and E. Stepina Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption Clin Cancer Res 15 11 2009 3751 3759
94. A.L. Zhang, and P.J. Russell Paclitaxel suppresses the growth of primary prostate tumours (RM-1) and metastases in the lung in C57BL/6 mice Cancer Lett 233 1 2006 185 191 (Pubitemid 43214578)
95. Furmanova P, Eggel M, Millard A, Pruschy M. The microtubule stabilizer Patupilone counteracts ionizing radiation-induced matrix metalloproteinase activity and tumor cell invasion, submitted for publication.